Welcome to our dedicated page for ROCKET ONE news (Ticker: RKTO), a resource for investors and traders seeking the latest updates and insights on ROCKET ONE stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ROCKET ONE's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ROCKET ONE's position in the market.
Rocket One (Nasdaq: RKTO) launched Swarm Stage AI™, an autonomous swarm simulation and defense platform for counter-drone training, critical infrastructure protection, and space security. The system is based on swarm-coordination IP acquired from SkyStage and marks Rocket One’s entry into autonomous defense systems.
The platform enables realistic training against saturation attacks, multi-vector incursions, electronic warfare, and adversarial AI swarms, while aligning with Rocket One’s three strategic pillars: nanomagnetic AI computing, radiation-tolerant space computing, and autonomous swarm defense systems.
Rocket One (Nasdaq: RKTO) outlined its strategy in advanced computing, AI infrastructure, space systems, and defense technologies. As of June 12, 2026, it held approximately $8.4 million in cash and cash equivalents, primarily from its at-the-market equity program.
The company secured two exclusive licenses for spintronic and nanomagnetic computing technologies aimed at AI and data-center applications, and expanded its space and defense advisory board. Rocket One also retains its legacy biotechnology portfolio, including HT-001 in Phase 2 development, and is exploring strategic alternatives for these assets.
Rocket One (Nasdaq: RKTO) appointed former NASA astronaut and International Space Station Commander Colonel (Ret.) Robert “Shane” Kimbrough to its Space Advisory Board. Kimbrough adds 30+ years of leadership in military aviation, human spaceflight, and aerospace technology as Rocket One advances space-focused computing and AI infrastructure.
Rocket One (Nasdaq: RKTO) appointed retired U.S. Army Major General Malcolm B. Frost to its Space and Defense Advisory Board. He brings nearly 40 years of national security and leadership experience, including 31 years in the Army.
According to Rocket One, his background supports its focus on AI computing, advanced semiconductors, and space and defense applications.
Rocket One (Nasdaq:RKTO) appointed Dr. Supriyo Bandyopadhyay as Lead Technical Advisor of AI Nanomagnetic Technology on June 1, 2026. He will guide development of Rocket One's radiation-tolerant, ultra-low-power nanomagnetic AI chip platform for orbital economy, space and defense applications, strengthening ties to his foundational nanomagnetics and spintronics research.
Rocket One (NASDAQ: RKTO) has been accepted into the AMD AI Developer Program, gaining access to AI development resources, potential cloud credits, training, and tools. The company plans to use these to model and simulate licensed nanomagnetic and spintronic semiconductor technologies for AI, defense, autonomous systems, and space applications, aiming to improve computational efficiency and energy consumption in advanced AI workloads.
Rocket One (Nasdaq: RKTO), formerly Hoth Therapeutics (HOTH), has completed its corporate name change and strategic pivot to the space economy. Common stock will stop trading as HOTH on May 27, 2026 and begin as RKTO on May 28, 2026.
The company holds exclusive rights to a next-generation nanomagnetic AI chip architecture designed for ultra-low-power, radiation-tolerant computing aimed at satellites, defense platforms, and space-based AI systems. Legacy biotechnology programs will continue under a wholly owned subsidiary.